Conference Correspondent 

Trastuzumab is a monoclonal antibody used for the treatment of HER2-positive breast cancer. Despite the efficacy of trastuzumab in the adjuvant setting, 1 in 4 patients experience disease recurrence. Neratinib is a potent, irreversible, pan-HER tyrosine kinase inhibitor that can combat mechanisms of disease escape and recurrence experienced with other HER2-targeted therapies. Read More ›

Educating Your Patients About Daratumumab
Leslie Lauersdorf insist that it's vital to inform your patients about what's involved in beginning daratumumab treatments, especially because of the lengthy chair time. Read More ›

How to Handle Survivorship Care for Multiple Myeloma
Tiffany Richards insists on the importance of survivorship care in patients with multiple myeloma and explains how to make sure patients stay as healthy as possible for as long as possible. Read More ›

How to Utilize New Mutliple Myeloma Drugs
Tiffany Richards is excited about all the new multiple myeloma treatments that are being introduced, but understands that the question of how to best utilize these drugs still remains to be answered. Read More ›

Preparing Your Patients for Side Effects
Tiffany Richards stresses the importance of educating patients about side effects and what to do when these side effects begin to present. Read More ›

Know Your Patients' Baselines
Tiffany Richards shares anecdotes that illustrate why it's important to really know your patients in order to effectively care for them. Read More ›

Meeting the Needs of the Patient
Tiffany Richards discusses the numerous, often unmet, needs of patients with multiple myeloma. Read More ›

Common Questions About Daratumumab
Tiffany Richards provides an overview of the most common questions she hears from patients regarding daratumumab. Read More ›

Daratumumab: An Overview
Tiffany Richards expresses her positive outlook on daratumumab, citing that the treatment has helped extend life expentancies. Read More ›

Challenges with Managing Patients with Malignant Diseases
Tiffany Richards explains the difficulties she has encountered in managing patients who have battled myeloma for an extended period of time and have experienced multiple relapses. Read More ›

Page 21 of 31


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: